Applications
Researchers Successfully 3D Print Muscle Tissues
The additive manufacturing industry has experienced strong growth in recent years and opened up new opportunities in numerous professional fields. In addition to the automotive sector or aerospace, 3D printing is finding more and more applications especially in the medical&hellip
- 3 min read
- Applications
- Six more stories

The additive manufacturing industry has experienced strong growth in recent years and opened up new opportunities in numerous professional fields. In addition to the automotive sector or aerospace, 3D printing is finding more and more applications especially in the medical sector and is now convincing with innovations that can save lives. Now, researchers at the Terasaki Institute for Biomedical Innovation have developed a fascinating new application that can enable the first production and trial of 3D printed muscle tissue.
Nowadays, it is possible to replace lost muscle tissue with the so-called autologous transfer. In this procedure, healthy muscle mass is taken from another part of the patient’s body to be used as a replacement for the missing tissue. Unfortunately, complications can arise during the transplantation process and loss of muscle in other parts of the body, which is why this approach should ideally be avoided. To remedy this, researchers at the institute have now developed a bioink designed to mimic natural muscle formation in order to produce synthetic muscle tissue. This innovative technology could be a promising solution for replacing muscle mass lost through injury, disease or surgery.

The bioink consists of a hydrogel, myoblast cells and microparticles (photo credits: Terasaki Institute)
The production of muscle tissue is a complex task, as it consists of different cell types and is regulated by biochemical and biomechanical signaling pathways. The researchers focused on the use of growth factor-1 (IGF-1), a hormone with an insulin-like structure that is required for normal bone and tissue growth. The bioink consists of three substances: a gelatin-based hydrogel, myoblast cells and polylactic acid (PLGA) microparticles coated with and continuously releasing IGF-1.





